
Michael E. Minshall, MPH
Articles by Michael E. Minshall, MPH


A predictive health economic model indicated that Roux-en-Y gastric bypass is cost-effective in the treatment of type 2 diabetes mellitus compared with medical management.



For patients with type 2 diabetes taking oral antidiabetics, self-monitoring of blood glucose cost-effectiveness (1 and 3 times per day) was modeled. Both strategies represented good value in the US payer setting.

Latest Updated Articles
- Conditional Economic Incentives Could Be Effective in Improving Adherence to Long-Acting PrEP in Transgender Adults
Published: August 18th 2025 | Updated: August 25th 2025
- Semaglutide Not Associated With Increased Risk of Eye Disorders
Published: August 19th 2025 | Updated: August 22nd 2025
- Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
Published: June 6th 2025 | Updated: August 18th 2025
- Report Reveals Mounting Burdens of Drug Shortages on US Health System
Published: June 27th 2025 | Updated: July 1st 2025
- Managed Care Reflections: Insights From Richard J. Gilfillan, MD; and Donald M. Berwick, MD, MPP
Published: February 20th 2025 | Updated: February 21st 2025
- FDA Proposal Aims to Reduce Smoking Addiction and SCLC Cases
Published: January 16th 2025 | Updated: January 29th 2025